Skip to content

BIORESTORATIVE THERAPIES, INC.: 10-Q filed 2022-11-14

What BIORESTORATIVE THERAPIES, INC. reported in its quarterly report filed 2022-11-14 (fiscal Q3 2022): 37 published measures, 103 facts as tagged in accession 0001493152-22-031668.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-14
Fiscal period
fiscal Q3 2022
Accession
0001493152-22-031668 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-3017,920,218USD
At 2021-12-3122,453,446USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-30915,903USD
At 2021-12-31856,497USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-3017,004,315USD
At 2022-06-3018,585,612USD
At 2022-03-3120,156,702USD
At 2021-12-3121,596,949USD
At 2021-09-30-4,879,304USD
At 2021-06-30-3,808,941USD
At 2021-03-31-2,694,382USD
At 2020-12-31-1,331,492USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-306,573,111USD
At 2021-12-3121,026,727USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-09-08 to 2022-09-30-4,655,825USD23
2022-07-01 to 2022-09-30-4,655,825USD92
2022-01-01 to 2022-09-30-14,147,216USD273
2022-04-01 to 2022-06-30-4,675,241USD91
2022-01-01 to 2022-03-31-4,816,150USD90
2021-07-01 to 2021-09-30-4,184,232USD92
2021-01-01 to 2021-09-30-23,900,157USD273
2021-04-01 to 2021-06-30-4,062,595USD91
2021-01-01 to 2021-03-31-15,653,330USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-4,297,412USD273
2021-01-01 to 2021-09-30-2,184,894USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-07-01 to 2022-09-3029,000USD92
2022-01-01 to 2022-09-30116,100USD273
2021-07-01 to 2021-09-308,000USD92
2021-01-01 to 2021-09-3041,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-30250,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-10,156,204USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-148,293,344USD
At 2021-12-31-134,146,128USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-07-01 to 2022-09-303,642,215shares92
2022-01-01 to 2022-09-303,602,979shares273
2021-07-01 to 2021-09-30838,689shares92
2021-01-01 to 2021-09-30788,564shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1.28USD/shares92
2022-01-01 to 2022-09-30-3.93USD/shares273
2021-07-01 to 2021-09-30-4.99USD/shares92
2021-01-01 to 2021-09-30-30.31USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-30231,324USD
At 2021-12-3137,993USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-30121,323USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,609,700USD92
2022-01-01 to 2022-09-30-14,292,121USD273
2021-07-01 to 2021-09-30-3,688,687USD92
2021-01-01 to 2021-09-30-22,298,606USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-3016,887,824USD
At 2021-12-3121,467,908USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-07-01 to 2022-09-3028,841USD92
2022-01-01 to 2022-09-30104,465USD273
2021-07-01 to 2021-09-30495,545USD92
2021-01-01 to 2021-09-301,601,551USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-30717,179USD
At 2021-12-31363,822USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-30468,501USD
At 2021-12-3150,827USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-09-30530,298USD
At 2021-12-31589,740USD
At 2020-12-31664,268USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-3045,000USD
At 2021-12-315,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-304,638,700USD92
2022-01-01 to 2022-09-3014,408,221USD273
2021-07-01 to 2021-09-303,696,687USD92
2021-01-01 to 2021-09-3022,339,606USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-30989,170USD92
2022-01-01 to 2022-09-302,839,731USD273
2021-07-01 to 2021-09-30237,410USD92
2021-01-01 to 2021-09-30563,562USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-303,646,450shares
At 2021-12-313,520,391shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-30165,281,862USD
At 2021-12-31155,727,292USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-30270,772USD
At 2021-12-31357,805USD
At 2021-09-30386,816USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-09-30332,755USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-09-30530,298USD
At 2021-12-31589,740USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-30114,647USD
At 2021-12-31134,970USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-30356,046USD
At 2021-12-31436,181USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-303,649,530USD92
2022-01-01 to 2022-09-3011,568,490USD273
2021-07-01 to 2021-09-303,459,277USD92
2021-01-01 to 2021-09-3021,776,044USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-09-3088,751USD273
2021-01-01 to 2021-09-3067,612USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-01-01 to 2022-09-3059,442USD273
2021-01-01 to 2021-12-3174,528USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-46,125USD92
2022-01-01 to 2022-09-30144,905USD273
2021-07-01 to 2021-09-30-495,545USD92
2021-01-01 to 2021-09-30-1,601,551USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-01-01 to 2022-09-30122,349USD273
2021-01-01 to 2021-09-30118,779USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-3040,000USD273
2021-01-01 to 2021-09-30-9,000USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30417,674USD273
2021-01-01 to 2021-09-305,707USD273

Inspect the source

Entity
BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
Captured
2026-09-19T11:18:28.483Z
SEC response SHA-256
fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))